Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran
Author(s) -
Payal Kakadiya,
Robert T. Higginson,
Patricia Pecora Fulco
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02275-17
Subject(s) - cobicistat , ritonavir , dabigatran , pharmacology , medicine , protease inhibitor (pharmacology) , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , atrial fibrillation , viral load , warfarin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom